Pfizer and Abzena have entered into an agreement under which Pfizer will acquire Abzena’s manufacturing facility in Sanford, NC. Upon completion of the construction, the state-of-the-art facility will have extensive capabilities for producing biologics drug substance and provides additional manufacturing capacity allowing Pfizer to help accelerate its pipeline. In addition, Abzena and Pfizer’s CentreOne contract manufacturing organization will collaborate to advance complex biologic products to ...